Subtotal excision with adjunctive sclerosing therapy for the treatment of severe symptomatic orbital lymphangiomas.

Abstract

Orbital lymphangiomas are congenital malformations with abnormal and dead-end lymphatic channels and present management challenges to ophthalmologists and orbital surgeons. Recurrent hemorrhage and expansion can lead to vision loss and disfigurement. We report our technique that uses adjunctive intraoperative injection of sodium morrhuate, 5%, under direct visualization into lymphangioma channels prior to excision. We believe that in the hands of experienced orbital surgeons, and with appropriate preoperative evaluation and careful surgical technique, this procedure is useful in saving vision and avoiding complications from orbital lymphangiomas.

• Authors: Alon Kahana, Brenda L Bohnsack, Raymond I Cho, Cormac O Maher
• Journal: Archives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 129 Issue 8 Pg. 1073-6 (Aug 2011) ISSN: 1538-3601 [Electronic] United States
• PMID: 21825192 (Publication Type: Case Reports, Journal Article)

Chemical References

• Sclerosing Solutions
• Sodium Morrhuate

Topics

• Adult
• Chemotherapy, Adjuvant
• Child
• Female
• Humans
• Injections, Intralesional
• Intraoperative Care
• Lymphangioma (diagnostic imaging, pathology, surgery, therapy)
• Magnetic Resonance Angiography
• Ophthalmologic Surgical Procedures
• Orbital Neoplasms (diagnostic imaging, pathology, surgery, therapy)
• Retrospective Studies
• Sclerosing Solutions (therapeutic use)
• Sodium Morrhuate (therapeutic use)
• Tomography, X-Ray Computed